Centrale del Latte d'italia

Similar documents
Centrale del Latte d'italia

Centrale del Latte d'italia

Eddie Stobart Logistics

Paysafe Group. Growth normalises. Growth moderates in H117. Pro forma financials show potential impact of deals

JackpotJoy plc. A transformational year. Revenue and EBITDA slightly ahead of estimates. Strong operating cash flow dividends from 2019

TXT e-solutions. Strong cash flow supports dividend boost. PACE acquisition boosts FY16 performance. Minor changes to earnings forecasts

Gear4music Holdings. Market share gains and margin boost. Strong pre-christmas trading. FY18 forecast maintained

TerraNet Holding. Irons in the fire. Five new strategic development orders won in Q317. Cash flow burn reflecting multi-project activity

Evolva. EverSweet. Delivering on the new strategy. FY17 results. Valuation: Fair value of CHF0.60 per share. FY17 results.

Mondo TV. YooHoo! Netflix deal drives significant upgrades. Global deal with Netflix, new Chinese productions. Significant increase to five-year plan

GB Group. PCA acquisition an excellent fit. PCA adds SME reach to address intelligence services. Earnings enhancing despite growth investment

Carr s Group. Diversification continues to give resilience. PBT up for H117 as UK farmers gain in confidence

TXT e-solutions. Steady growth in Q3. Growth for both businesses in Q3. Outlook and changes to forecasts

XP Power. Strong demand drives record performance in H1. H118 sees continuation of strong growth

Piteco. Bold entry into the US marketplace. Acquisition of US payments software provider. Forecasts: FY18 revenues rise by 34%, EPS by 12%

ReNeuron Group. US exclusivity deal - more than non-dilutive cash. FY18 results: Strong cash balance. Funded for a busy programme

K3 Business Technology

OTC Markets Group. Record quarterly revenues. Q115 Corporate services revenue rises 54% Operating expenses rise 18% in Q115.

International Stem Cell

Regional REIT. Asset growth and refinancing completed. Further portfolio growth and diversification. Acquisition benefit offset by underlying revision

Sealegs Corporation. Sea change. H1 update. Changing business mix. Valuation: New focus improves valuation. H1 results

Circle Property. Lifting estimates again. Revaluation gains and strong rent growth. Upside potential from refurbished assets

KEFI Minerals. Counting down to production. Outstanding matters. Valuation: 6.55p/sh in FY18 rising to 7.21p/sh in FY19.

Shanks Group. Global commodity crisis offsetting progress. Netherlands Commercial progress encouraging

Cooks Global Foods. Focused on capital requirements results restated. CGF budgets for 650 stores, targets 800 by 2021

LPE sector performance

Helma Eigenheimbau. Scale research report - Update. Market bottlenecks limiting momentum. H117 results showing moderate growth

GFT Group. IT services pure-play focused on banks. Disposal of emagine. Acquisition of Adesis Netlife SL. Forecasts: Adjusted for effects of the deals

GLG Life Tech. Luo Han Guo drives revenue growth. Tate & Lyle LHG contract boosts top line. H3 and H4 leaf should improve stevia margins

Progress in a backward market

Mondo TV. Guidance raised for full year. H117 highlights: Strong licensing sales. Outlook: Net profit guidance raised

Medserv. Pieces fitting into place H118. On track to deliver growth. Valuation: Backlog underpins uplift. H118 results. Industrial support services

artnet For art's sake FY15: Art fair partnerships and forays to China Intended reporting change Valuation: Overshadowed Q1 figures

K3 Business Technology

Quixant. A very promising year ahead. Volume deliveries to new major customers. Current order book over double the prior year

Regional REIT. Retail eligible bond 4.5% Regional markets have remained robust. Retail eligible bond offering. Launch of bond issue.

Monitise. FY14 growth on track. Focus on expanding the network. Guidance maintained for FY14. Valuation: Reflects growth potential.

The Quarto Group. Good visibility into H2. Building on strengths. Group in improving shape for CFO transition. Valuation: Discount remains substantial

Carclo. Contract delays to affect H218 performance. Delayed placement of contracts by customers. Non-medical demand lower than forecast.

Antofagasta. Q3 production and costs better than forecast. Q313 production ahead of forecast. FY13 EPS forecast upgraded

Carclo. All going to plan. TP benefiting from expansion to support customers. FLTC acquisition supports further Wipac growth

Tourism Holdings. ROCE exceeds 14% long-term target. Key drivers remain positive. Deeper customer relationships to drive yield

Carr's Group. Profits dip as expected with FY18 recovery underway. FY17 impacted by external factors. FY18 recovery underway

China Water Affairs Group

Oceania Natural. NXT Company Spotlight. Preliminary results and delisting proposal. Preliminary results at March 2018: Increased loss

Aberdeen Asset Management

Ubisense. Geographic expansion. Ubisense acquires Asian partner. Expanding the opportunity in Asia. Changes to forecasts

Evolva. A cloudier picture. Production update agreement not yet reached. FY16 revenue lower than previously expected

Avalon Rare Metals. Refining Nechalacho s future. Nechalacho changing shape significantly. Agreement with Northwest Territory Métis Nation

Polypipe Group. Strong Residential performance. Sector themes maintained, some portfolio tweaks. French disposal modestly dilutive to earnings

Cooks Global Foods. Funded for growth. Growth plans. Interim results. Valuation: Upside in valuation. Interim results.

Expert System. Building the foundations for growth. Contract wins delayed by integration efforts. Company confident that outlook remains positive

TransContainer. Russian rail volumes continue to grow. Story intact: Runaway market growth. EBITDA growth set to continue

paragon Accelerating progress Q2 displays accelerating performance Guidance changes reflect growth initiatives Valuation: Rating not reflecting growth

Global Bioenergies. String of successes and new financing. Forecasts updated to reflect results & new financing

Rockhopper Exploration

Vectron Systems. Scale research report - Update. Evolving the business. Boost from regulatory changes recedes. Increased focus on cloud services

Pura Vida Energy. Reaction to drilling. Sharp sell-off on no news. Results expected no earlier than late July. Increased stock volatility not unusual

SNP Schneider-Neureither & Partner

WANdisco. Cloud OEM agreement with Virtustream/Dell. Second OEM, first for cloud. Cloud credentials strengthened

Record. Maintaining client commitment. FY18 result. Outlook: Seeing well-diversified interest. Valuation. FY18 results. Financial services

NAHL Group. Maiden interims show strong profit growth. Significant rise in margins in H114. FY14e and FY15e PBT and EPS estimates raised

Centrale del Latte di Torino

High-impact exploration offshore Philippines

S&U. Positioning for sustainable growth. H119 results. Adapting to market background. Valuation: Maintained on slightly lower estimates.

Bionomics. PTSD programme on track for results in Q3. PTSD treatment complete, results coming. Agitation study ongoing

Game Digital. Not a game changer. Early days in the strategic transition. Trading update: Short-term timing delays

Boku. Strong H1 supports future growth. Strong volume growth continues in H118. Investing for sustained growth. Valuation: Premium for growth

InMed Pharmaceuticals

Ceres Power Holdings. Progressing towards commercialisation. Progressing the technology. Securing routes to market

Kongsberg Automotive investment headwind, but technology wins results affected by investment, but progress

Mercia Technologies. Good progress across the portfolio. 17.7% growth in direct investment portfolio. Commercial traction in key companies

ADVA Optical Networking FY12 results

Caledonia Mining. Production in line, EPS down on macro factors. Record quarterly production. New (lower) gold price forecasts

Entertainment One. PJ Masks catching Peppa. Strong growth in profitability. PJ Masks joins Peppa as a global Family brand

Expert System. Turning the AI hype into reality. Pace of new business accelerated in H2. Increasing interest in commercial application of AI

Athersys. Progress on all fronts. Timeline for FDA approval accelerated. mrs shift analysis is primary endpoint. Moving forward in Japan

Park Group. Continued growth in earnings and cash. Small forecast increase, awaiting IFRS 15. New management team takes up the baton

SITO Mobile. A strong end to a transformational year. Transformational year ends on a high note. Pipeline looks promising

Sigma Capital Group. New funding structure to finance project growth. JV to deliver initial 200m portfolio of 2,000 homes.

Thin Film Electronics

DeA Capital. Expanding asset management platform. AUM growth accelerates in Q4. A healthy net investment balance supports dividends

The Quarto Group. 40 years young. Children s list delivers on promise. Investing in new titles, building IP for future sales

Tungsten Corporation. Focusing on growth and efficiency. AGM update. Outlook. Valuation. Company update. Financial services

Intec Pharma. Phase III more than half the way there. Gastroscopy substudy complete. New pharmacokinetic study on deck. New plan for AP cannabinoids

Pantaflix. Scale research report Update. Name change reflects VOD strategy. Progressing its VOD strategy. Overview of H117 results

AFH Financial Group. Delivering on acquisitions and organic growth. FY15 results: Beating expectations on organic growth

PPHE Hotel Group. More of the same. Continued outperformance. Favourable asset management climate. Valuation: Closing the discount to NAV

La Doria. Strength in a tough environment. Strong Q118 results. Shaping the business for the future. Valuation: per share.

Ceres Power Holdings. Strengthening customer engagement. Customer engagement intensifying. Engagement underpinned by technology advances

Mondo TV. Exploring new horizons. FY18 on course for another step increase in EBITDA. Considering investment in new Chinese theme park

aap Implantate AG Biomaterials for sale as LOQTEQ growth takes off Robust growth driven by LOQTEQ in FY14 Sale of Biomaterials under review

German Startups Group

TransGlobe Energy. EGPC receivables issue resolved. EGPC makes significant receivables reduction. Focus in Egypt shifts from seismic to drilling

Game Digital. Sales recovery sees strategy on track. Switch comes through. Results on expectation. Transformation strategy on track

Deutsche Beteiligungs

RNTS Media. Scaling up with acquisitions. Mediation platform very well received. Product launches - growth should pick up in H2

Bellus Health. Thallion deal likely as Jaguar backs revised CVRs. CVR revisions mostly modest; Jaguar supports bid

La Doria. As expected. Weak Q117 results, as anticipated. The right strategy. Valuation: Remains attractive. Q117 results.

Photocure. Nordic sales bounce back. Eight more blue light cystoscopy units placed in US. Hexvix/Cysview added to bladder cancer guidelines

Transcription:

Centrale del Latte d'italia Strong revenue growth H117 results Food & beverages Price increases implemented during the course of H117 have been successful and organic sales growth of 4.8% is impressive. This leads us to raise our revenue forecasts for Centrale del Latte d Italia (CLI) by 2% and our profit forecasts rise by 5-11%. Management expects the recovery to continue into Q317 and beyond as the full effect of the price increases comes through. Our fair value rises to 2.94 (from 2.82). Year end Revenue ( m) PBT* ( m) EPS* (c) DPS (c) P/E (x) Yield (%) 12/15 98.3 0.46 0.30 6.00 986.7 2.0 12/16 119.8 (2.09) (19.57) 6.00 N/A 2.0 12/17e 181.0 0.60 4.40 6.00 67.3 2.0 12/18e 181.9 1.09 8.01 6.00 37.0 2.0 Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. 9 August 2017 Price 2.96 Market cap 42m Net debt ( m) at 31 December 2016 60.2 Shares in issue 14.0m Free float 41% Code CLI Primary exchange STAR (Borsa Italiana) Secondary exchange N/A Share price performance Price increases drive top-line growth Price increases were implemented on 1 April in order to offset some cost inflation, but they were fully rolled out on 1 June. In addition spot milk prices have started to fall, so the backdrop for H217 is far more benign. We continue to forecast an EBITDA margin of 4.8% for FY17 vs 2.7% in H117, hence implying 7.0% margin during the balance of 2017, which should be achievable given the price increases that have been put through. Strategic focus paying off CLI s focus on its core geographical markets and its brands has ensured consumers are willing to withstand price increases on its products. Market share has grown in value terms across a number of segments, and CLI has retained its position as the third-largest dairy player in Italy. It remains the market leader in fresh and extended shelf life (ESL) milk, and UHT milk in the regions where it operates (Piedmont, Lombardy, Tuscany and Veneto). The company now expects some recovery in the overall market over the course of H217, and we believe it is in a good position to benefit from this. Valuation: Fair value of 2.94 per share Our DCF model points to a fair value of 2.94 per share (from 2.82), implying that the stock is fairly valued. We calculate that for FY17e CLI now trades at 67.3x P/E and 11.3x EV/EBITDA, with a 2.0% dividend yield. The P/E is inflated in part due to the high interest costs as a result of the elevated debt level in the short term associated with the merger by incorporation with Centrale del Latte di Firenze (CLF) in September 2016 (detailed in our note). We expect these to normalise by 2019. On EV/EBITDA, CLI trades at a premium of 15% to the average of our peer group of dairy processors. % 1m 3m 12m Abs 6.2 3.3 1.7 Rel (local) 1.3 0.4 (23.0) 52-week high/low 3.3 2.7 Business description Centrale del Latte d Italia produces and distributes fresh and long-life milk (UHT and ESL), and dairy products such as cream, yoghurt and cheese. It has a leading position in milk in the Piedmont region of northern Italy, and it has expanded to the Veneto, Liguria and Tuscany regions. Next events 9m17 results 10 November 2017 Analysts Sara Welford +44 (0)20 3077 5700 Paul Hickman +44 (0)20 3681 2501 consumer@edisongroup.com Edison profile page Centrale del Latte d'italia is a research client of Edison Investment Research Limited

H117 results review CLI s total H117 revenue of 90.5m compares to revenue of 48.8m in H116. While most of the growth was of course due to the merger with CLF, the group did also witness an impressive level of underlying organic growth, at c 5%. Price increases implemented through H117 have been successfully received by consumers and the full effect is expected to come through from Q317. Sales of bulk milk and cream increased significantly due to higher spot prices, vegetable drinks witnessed strong growth as the category as a whole is still being buoyed by consumer trends, and exports also improved significantly. Market share data confirm the positive sales trends: CLI grew its share in fresh milk, UHT milk and yoghurt, both in the Italian market overall and in the specific regions where it operates, ie Piedmont, Liguria, Tuscany and Veneto (source: IRI Infoscan). CLI retained its position as the third dairy player in Italy by growing its market share by value from 7.3% to 7.7% in fresh and ESL milk, and from 3.7% to 3.9% in UHT milk. It continues to be market leader in the regions where it operates, with value share of 28.5% in fresh and ESL milk (vs 27.6% in 2016), and 14.4% share in UHT milk, which represents 110bps growth vs the prior year. EBITDA of 2.5m in H117 compares with 1.6m in H116, though margins were down 40bps to 2.7%. There was a significant recovery during Q2, as margins were 1.5% in Q117. The recovery was mainly driven by the above-mentioned price increases and also better cost control. Given the positive effect of the price increases that have been implemented through H117, management expects the recovery to continue into Q317 and beyond. Exhibit 1: Organic revenue growth by division H116 ( 000) H117 ( 000) M&A ( 000) Organic growth Organic growth ( 000) Fresh milk 20,669 36,637 15,987 (19) -0.1% UHT milk 9,088 19,080 9,874 118 1.3% Yoghurt 3,444 4,411 1,149 (182) -5.3% Salads 2,980 3,302 321 1 0.0% Bulk milk & cream 1,194 2,129 457 478 40.0% Other 10,069 22,890 11,413 1,408 14.0% Vegetable drinks 815 1,348 190 344 42.1% Export 524 737 0 213 40.6% Total 48,784 90,534 39,390 2,360 4.8% Source: Centrale del Latte d Italia data, Edison Investment Research Financials We raise our organic revenue growth forecast for FY17 from 1% to 4% on the back of encouraging H117 results. We leave our margin forecasts unchanged, which means our FY17 EBITDA forecast increases to 8.7m (from 8.5m) and net income increases to 0.39m from 0.35m. We illustrate the changes to our key forecasts in Exhibit 2. Exhibit 2: Old vs new forecasts, 000s 2017e 2018e 2019e Old New % change Old New % change Old New % change Revenue 177,464 180,998 2.0% 178,351 181,903 2.0% 179,243 182,812 2.0% EBITDA 8,547 8,717 2.0% 8,946 9,124 2.0% 9,349 9,536 2.0% PBT 537 598 11.4% 1,016 1,088 7.1% 1,839 1,929 4.9% Net income 349 389 11.4% 661 707 7.1% 1,195 1,254 4.9% EPS (reported), 0.02 0.03 11.4% 0.05 0.05 7.1% 0.09 0.09 4.9% Source: Edison Investment Research Centrale del Latte d'italia 9 August 2017 2

Valuation CLI s share price has increased 2.4% over the last three months vs the FTSE MIB, which is up 3.6%. It has also underperformed relative to the FTSE MIB on a six- and 12-month basis. On 2017 estimates, CLI trades at 67.3x P/E and 11.3x EV/EBITDA, with a 2.0% dividend yield. The P/E is inflated due to the high level of debt following the merger, and hence the high interest costs. These contribute to a squeeze on earnings. The leverage in the business means we expect earnings to return to a more normal level by FY19. On EV/EBITDA, CLI trades at a premium of 14.6% to the average of our peer group of dairy processors (although we note the peer group companies are much larger than CLI). Exhibit 3: Benchmark valuation of CLI relative to peers Market cap (m) P/E (x) EV/EBITDA (x) Dividend yield (%) 2017e 2018e 2017e 2018e 2017e 2018e Parmalat 5,691.6 31.0 30.7 9.8 8.2 0.6% 0.6% Dairy Crest 836.6 15.7 14.9 11.7 11.1 3.9% 4.0% Dean Foods $1,340.5 11.5 10.7 5.1 4.7 2.6% 2.8% Saputo $16,846.8 21.4 19.6 12.7 11.7 1.5% 1.6% Peer group average 19.9 19.0 9.8 8.9 2.1% 2.3% CLI 40.7 66.1 36.3 11.2 10.7 2.1% 2.1% Premium/(discount) to peer group (%) 232.3% 91.3% 14.6% 20.2% -3.5% -8.9% Source: Edison Investment Research estimates and Bloomberg consensus. Note: Prices at 7 August 2017. We use DCF analysis to value the shares and calculate a fair value of 2.94 (previously 2.82), implying the stock is fairly valued. We have assumed no cost synergies from the merger with CLF, which is in line with company guidance. We have also rolled forward our DCF to 2018. Our DCF is based on our (unchanged) assumptions of 1.5% terminal growth rate and 3% terminal EBIT margin. Our WACC of 5.8% is based on an equity risk premium of 4.5%, a borrowing spread of 5% and beta of 0.9. Below, we show a sensitivity analysis to these assumptions and note that the current share price is discounting a terminal EBIT margin of 2.9% (which compares to CLT s reported EBIT margin of 2.7% in 2014 and 1.6% in 2015; Centrale del Latte di Torino, or CLT, merged with CLF in September 2016, and the new entity was renamed Centrale del Latte d Italia), with a terminal growth rate of c 1.5%. Exhibit 4: DCF sensitivity ( /share) to terminal growth rate and EBIT margin Terminal growth Terminal EBIT margin 2.00% 2.50% 3.00% 3.50% 4.00% 4.50% 0.00% 0.85 1.35 1.85 2.35 2.85 3.34 0.50% 1.04 1.59 2.14 2.69 3.24 3.79 1.00% 1.28 1.89 2.50 3.11 3.72 4.33 1.50% 1.57 2.26 2.94 3.62 4.31 4.99 2.00% 1.94 2.72 3.50 4.27 5.05 5.83 2.50% 2.42 3.32 4.22 5.12 6.02 6.92 3.00% 3.07 4.14 5.20 6.27 7.33 8.40 3.50% 4.01 5.31 6.61 7.92 9.22 10.53 4.00% 5.46 7.14 8.81 10.49 12.16 13.83 Source: Edison Investment Research Centrale del Latte d'italia 9 August 2017 3

Exhibit 5: Financial summary 000s 2013 2014 2015 2016 2017e 2018e 2019e 2020e Year end 31 December IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS INCOME STATEMENT Revenue 99,967 102,558 98,319 119,762 180,998 181,903 182,812 183,726 Cost of Sales (80,923) (82,415) (78,796) (98,652) (144,486) (145,026) (145,568) (146,113) Gross Profit 19,044 20,143 19,523 21,110 36,512 36,877 37,244 37,614 EBITDA 4,911 5,845 4,851 2,905 8,717 9,124 9,536 9,951 Normalised operating profit 1,379 2,752 1,554 (1,254) 2,737 3,230 4,065 4,453 Amortisation of acquired intangibles 0 0 0 0 0 0 0 0 Exceptionals (250) (134) 145 (355) 0 0 0 0 Share-based payments 0 0 0 0 0 0 0 0 Reported operating profit 1,129 2,618 1,699 (1,609) 2,737 3,230 4,065 4,453 Net Interest (675) (811) (678) (692) (1,996) (1,999) (1,993) (1,979) Joint ventures & associates (post tax) (4) (4) (418) (143) (143) (143) (143) (143) Exceptionals 1,646 0 0 13,903 0 0 0 0 Profit Before Tax (norm) 2,347 1,937 458 (2,089) 598 1,088 1,929 2,331 Profit Before Tax (reported) 2,097 1,803 603 11,459 598 1,088 1,929 2,331 Reported tax (827) (1,012) (87) 556 (209) (381) (675) (816) Profit After Tax (norm) 2,042 809 30 (2,153) 616 1,121 1,988 2,402 Profit After Tax (reported) 1,270 791 517 12,015 389 707 1,254 1,515 Minority interests 0 0 0 0 0 0 0 0 Discontinued operations 0 0 0 0 0 0 0 0 Net income (normalised) 2,042 809 30 (2,153) 616 1,121 1,988 2,402 Net income (reported) 1,270 791 517 12,015 389 707 1,254 1,515 Basic average number of shares outstanding (m) 10 10 10 11 14 14 14 14 EPS - basic normalised ( ) 0.20 0.08 0.00 (0.20) 0.04 0.08 0.14 0.17 EPS - diluted normalised ( ) 0.20 0.08 0.00 (0.20) 0.04 0.08 0.14 0.17 EPS - basic reported ( ) 0.13 0.08 0.05 1.09 0.03 0.05 0.09 0.11 Dividend ( ) 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 Revenue growth (%) N/A 2.6 (-4.1) 21.8 51.1 0.5 0.5 0.5 Gross Margin (%) 19.0 19.6 19.9 17.6 20.2 20.3 20.4 20.5 EBITDA Margin (%) 4.9 5.7 4.9 2.4 4.8 5.0 5.2 5.4 Normalised Operating Margin 1.4 2.7 1.6-1.0 1.5 1.8 2.2 2.4 BALANCE SHEET Fixed Assets 65,064 64,185 64,540 129,773 129,404 129,331 129,527 129,725 Intangible Assets 11,777 11,706 11,539 19,484 19,411 19,337 19,264 19,191 Tangible Assets 52,652 51,671 52,010 107,335 107,039 107,039 107,309 107,581 Investments & other 634 808 992 2,954 2,954 2,954 2,954 2,954 Current Assets 35,647 36,689 41,122 60,457 73,127 73,303 73,756 74,469 Stocks 3,473 3,438 3,541 7,698 11,274 11,316 11,358 11,401 Debtors 16,210 15,720 14,370 28,209 43,347 43,564 43,782 44,001 Cash & cash equivalents 7,822 10,051 12,192 9,521 3,213 3,130 3,323 3,775 Other 8,141 7,481 11,019 15,030 15,293 15,293 15,293 15,293 Current Liabilities (34,211) (33,232) (35,004) (68,199) (88,135) (88,370) (88,606) (88,843) Creditors (23,402) (23,744) (24,247) (42,910) (62,845) (63,081) (63,316) (63,553) Tax and social security (333) (468) (357) (697) (697) (697) (697) (697) Short term borrowings (10,475) (9,021) (10,401) (24,592) (24,592) (24,592) (24,592) (24,592) Other 0 0 0 0 0 0 0 0 Long Term Liabilities (25,776) (27,178) (29,847) (58,489) (51,306) (51,306) (51,306) (51,306) Long term borrowings (17,297) (18,219) (22,446) (45,159) (45,159) (45,159) (45,159) (45,159) Other long term liabilities (8,479) (8,960) (7,402) (13,330) (6,147) (6,147) (6,147) (6,147) Net Assets 40,723 40,464 40,810 63,542 63,090 62,958 63,371 64,046 Minority interests 0 0 0 0 0 0 0 0 Shareholders' equity 40,723 40,464 40,810 63,542 63,090 62,958 63,371 64,046 CASH FLOW Op Cash Flow before WC and tax 4,911 5,845 4,851 2,905 8,717 9,124 9,536 9,951 Working capital 1,715 1,811 (1,942) (30) (2,119) (24) (24) (25) Exceptional & other 31 (129) (1,262) (15,092) (143) (143) (143) (143) Tax (827) (1,012) (87) 556 (209) (381) (675) (816) Net operating cash flow 5,829 6,515 1,560 (11,661) 6,245 8,576 8,693 8,967 Capex (781) (2,107) (3,914) (4,095) (5,611) (5,821) (5,667) (5,696) Acquisitions/disposals 0 0 0 0 0 0 0 0 Net interest (675) (811) (678) (692) (1,996) (1,999) (1,993) (1,979) Equity financing 0 0 0 0 0 0 0 0 Dividends (200) (600) (600) (600) (840) (840) (840) (840) Other (5,923) 2,293 5,031 (1,131) 0 0 0 0 Net Cash Flow (1,748) 5,291 1,399 (18,178) (2,202) (83) 193 452 Opening net debt/(cash) 25,676 19,950 17,189 20,654 60,230 66,538 66,621 66,428 FX 0 0 0 0 0 0 0 0 Other non-cash movements 7,474 (2,529) (4,865) (21,397) (4,107) 0 0 0 Closing net debt/(cash) 19,950 17,189 20,654 60,230 66,538 66,621 66,428 65,976 Source: Edison Investment Research, Centrale del Latte d Italia data Centrale del Latte d'italia 9 August 2017 4

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com DISCLAIMER Copyright 2017 Edison Investment Research Limited. All rights reserved. This report has been commissioned by Centrale del Latte d'italia and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are wholesale clients for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performanc e or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a personalised service and, to the extent that it contains any financial advice, is intended only as a class service provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited ( FTSE ) FTSE 2017. FTSE is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE s express written consent. Frankfurt +49 (0)69 78 8076 960 Centrale Schumannstrasse del 34b Latte d'italia 9 August 280 High 2017 Holborn 295 Madison Avenue, 18th Floor Level 12, Office 1205 5 60325 Frankfurt Germany London +44 (0)20 3077 5700 London, WC1V 7EE United Kingdom New York +1 646 653 7026 10017, New York US Sydney +61 (0)2 8249 8342 95 Pitt Street, Sydney NSW 2000, Australia